SCHEMBL3159043

SCHEMBL3159043

NCCCNCCCNCCCNCCCNCCCN

nearest known ligand 0.92

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 5/20 0.86
CA6 P23280 5/20 0.86
CA7 P43166 5/20 0.86
CA9 Q16790 5/20 0.86
CA14 Q9ULX7 5/20 0.86
CA5B Q9Y2D0 5/20 0.86
CA2 P00918 4/20 0.86
CA4 P22748 4/20 0.86
CA5A P35218 4/20 0.86
ALOX15 P16050 3/20 0.86
CASP2 P42575 2/20 0.86
F13A1 P00488 2/20 0.86
CYP1A2 P05177 2/20 0.86
THPO P40225 2/20 0.86
MEN1 O00255 2/20 0.86
RECQL P46063 2/20 0.86
KMT2A Q03164 2/20 0.86
CYP2C19 P33261 1/20 0.86
HSD17B10 Q99714 1/20 0.86
CA3 P07451 3/20 0.80

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL868754 1.00 CA12 (0.86) CA12CA6CA7CA9CA14
SCHEMBL869691 1.00 CA12 (0.86) CA12CA6CA7CA9CA14
Thermine SCHEMBL181589 1.00 CA12 (0.86) CA12CA6CA7CA9CA14
SCHEMBL561809 1.00 CA12 (0.86) CA12CA6CA7CA9CA14
SCHEMBL869672 1.00 CA12 (0.86) CA12CA6CA7CA9CA14
SCHEMBL869496 1.00 CA12 (0.86) CA12CA6CA7CA9CA14
SCHEMBL870789 1.00 CA12 (0.86) CA12CA6CA7CA9CA14
SCHEMBL869794 1.00 CA12 (0.86) CA12CA6CA7CA9CA14
Thermine SCHEMBL8837088 0.96 CASP2 (0.93) CA12CA6CA7CA9CA14
SCHEMBL9718728 0.96 CASP2 (0.93) CA12CA6CA7CA9CA14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4731603-A1 LOW TEMPERATURE REACTIVE ARYL AZIDES SuSoS AG (CH) 2026-04-29 EP claimed
WO-2025070707-A1 COMPOSITION CONTAINING DIAMINE AND/OR POLYAMINE FOR PREVENTING OR IMPROVING FRAILTY 東洋紡株式会社 2025-04-03 WO claimed
WO-2024261308-A1 LOW TEMPERATURE REACTIVE ARYL AZIDES SUSOS AG (CH) 2024-12-26 WO claimed
WO-2024192269-A2 ENZYMATIC METHODS AND COMPOSITIONS FOR POLYMERIZATION OF PHOSPHORAMIDATE AND THIOPHOSPHORAMIDATE-LINKED DNA THE GENERAL HOSPITAL CORPORATION (US) 2024-09-19 WO claimed
US-20240309418-A1 ENZYMATIC METHODS AND COMPOSITIONS FOR POLYMERIZATION OF PHOSPHORAMIDATE AND THIOPHOSPHORAMIDATE-LINKED DNA MASSACHUSETTS GEN HOSPITAL (US) 2024-09-19 US claimed
US-11851555-B2 Polybutene derivative for rubber compounding and rubber composition including same DL CHEMICAL CO., LTD. (KR) 2023-12-26 US claimed
EP-3943317-B1 POLYBUTENE DERIVATIVE FOR RUBBER COMPOUNDING AND RUBBER COMPOSITION INCLUDING SAME DL CHEMICAL CO LTD (KR) 2023-09-06 EP claimed
US-20230101362-A1 RNA STABILIZATION TEAM MEDICAL LLC 2023-03-30 US claimed
US-20220313625-A1 PHARMACEUTICAL AGENT, MEDICINAL SOLUTION FOR CLEANING PULMONARY ALVEOLI, AND NEBULIZER OHKIDO, MAKIKO (JP) 2022-10-06 US claimed
US-20220144747-A1 SHIKIMATE ANALOGUES AND METHODS OF USE THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA 2022-05-12 US claimed
US-20060281820-A1 Lfa-1 inhibitors and use thereof SODA KUNIYASU 2006-12-14 US claimed
EP-4746852-A1 LIPID AGGREGATES FOR INTRAARTICULAR ADMINISTRATION Universität Bern (CH) 2026-05-27 EP disclosed
EP-4731603-A1 LOW TEMPERATURE REACTIVE ARYL AZIDES SuSoS AG (CH) 2026-04-29 EP disclosed
EP-4584349-A1 SYNTHETIC LUBRICITY ADDITIVES FOR HYDROCARBON FUELS ECOLAB USA INC. (US) 2025-07-16 EP disclosed
WO-2025109225-A1 METHOD FOR REDUCING DSRNA FORMATION DURING IVT ETHERNA IMMUNOTHERAPIES NV (BE) 2025-05-30 WO disclosed
US-5663125-A POLYETHERS, BORONATED AMINES NIPPON OIL CO., LTD. (JP) 1997-09-02 US disclosed
EP-0729938-A2 A method for producing aryl alkyl hydroperoxides MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1996-09-04 EP disclosed
EP-0636680-A1 LUBRICANT FOR A TWO CYCLE ENGINE Nippon Oil Co., Ltd. (JP) 1995-02-01 EP disclosed
US-4992150-A Telomer with alpha-olefin;oil and fuel additive NIPPON OIL CO, LTD. (JP) 1991-02-12 US disclosed
US-4011057-A HINDERED PHENOL ANTIOXIDANT COMPOSITION CONTAINING AN AMINO COMPOUND E. I. DU PONT DE NEMOURS AND COMPANY (US) 1977-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220144747-A1 SHIKIMATE ANALOGUES AND METHODS OF USE GRIK5, GRIK1, GRIK3 CA12 302/4885CA6 144/4885CA7 101/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.